GLWL-01

DRUG3 trials

Sponsors

GLWL Research Inc., University College, London, National Institute on Drug Abuse (NIDA)

Conditions

Alcohol Use DisorderAppetitive BehaviorBariatric Surgery CandidateObesityPrader-Willi Syndrome

Phase 1

Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder

CompletedNCT03896516

National Institute on Drug Abuse (NIDA)Alcohol Use Disorder

Start: 2021-06-22End: 2023-12-04Updated: 2025-01-15

Phase 2

A Study of GLWL-01 in Patients With Prader-Willi Syndrome

CompletedNCT03274856

GLWL Research Inc.Prader-Willi Syndrome

Start: 2018-02-20End: 2019-06-12Updated: 2020-03-27

Unknown Phase

Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery (BARI-INSIGHT)

CompletedNCT03641417

University College, LondonAppetitive Behavior, Bariatric Surgery Candidate, Obesity

Start: 2019-02-15End: 2020-03-13Updated: 2020-05-20